knowledge -WSS

knowledge

author：knowledge 2025-09-29 21:25:38 - browse：695

President of Bayer U.S. Sebastian Guth speaks with STAT reporters at STAT's Boston headquarters, March 13, 2024 — Bayer's U.S. president, Sebastian Guth, emphasized at an interview at the STAT offices in Boston that the pharma company is no longer just focused on small molecules. Alissa Ambrose/STAT

German pharmaceutical company Bayer is expanding its U.S. pharma business significantly, despite corporate turmoil and pricing pressures that have led many in the drug industry to bemoan the potential end of the American biotech innovation boom.

Bayer’s C-suite has been on a soul-searching mission for the last year, spurred by new leadership and the realization that the company is, as new CEO Bill Anderson said earlier this month, “badly broken.”

The biggest fissure is the debt and litigation costs stemming from Bayers’s 2018 acquisition of agriculture firm Monsanto, but the aspirin-maker’s pharmaceutical portfolio is also facing strain. Some of Bayer’s top products, including the anticoagulant drug Xarelto and the eye medication Eylea, are under patent pressure. Xarelto is also one of the first drugs to be subject to Medicare price negotiations under the Inflation Reduction Act, though Johnson & Johnson owns U.S. rights to the drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Criminal prosecution for violating HIPAA: an emerging threat

focus

WSS

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Emergent cuts jobs, executive role in business shake

Glen Campbell's doctor discusses his public struggle with Alzheimer's

American woman, child freed after being kidnapped in Haiti last month

Maui's cultural, historic landmarks damaged in the devastating wildfires

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

explore

knowledge

leisure time

Malaria cases in Florida and Texas: Here’s what you need to know

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

In age of alternative facts, a scholarly course on calling out crap

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Trump demands the U.S. pay no more for drugs than other countries … again

NIH trials fail to test meaningful long Covid therapies, experts say

Cancer drug shortages should be causing more outrage

Methadone doses haven’t kept up in the age of fentanyl

Novavax promises a turnaround & Lilly roils the obesity market

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

entertainment

Arc Institute generative AI designs new CRISPR systems

The best solution to the drug shortages problem

Second House panel advances two

NIH trials fail to test meaningful long Covid therapies, experts say

Maui's cultural, historic landmarks damaged in the devastating wildfires

When prostate cancer spreads, where it goes matters

focus

focus

explore

focus